Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples